| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer
1 company
Scheessele William John is a Chief Commercial Officer at Humacyte, Inc.. Recent SEC Form 4 filings include 3 buys and 0 sells.
Estimated insider holdings value: $25K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 14, 2025 | HUMA Humacyte, Inc. | Chief Commercial Officer | Buy | 6,493 | $1.54 | $9,999.22 | +41.8% | +65.8% | -56.7% | |
| Dec 13, 2022 | HUMA Humacyte, Inc. | Chief Commercial Officer | Buy | 5,000 | $3.09 | $15,450.00 | +47.5% | -5.7% | +3.2% | |
| May 24, 2022 | HUMA Humacyte, Inc. | Chief Commercial Officer | Buy | 10,525 | $4.72 | $49,678.00 | New | -11.3% | -17.6% |